Pinover WH - Search Results

1

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Uzzo RG, et al. Among authors: pinover wh. Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560

2

Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control.

Kaminski JM, Hanlon AL, Horwitz EM, Pinover WH, Mitra RK, Hanks GE. Kaminski JM, et al. Among authors: pinover wh. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):888-92. doi: 10.1016/s0360-3016(01)02764-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 11958880

3

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy.

Kramer NM, Hanlon AL, Horwitz EM, Pinover WH, Hanks GH. Kramer NM, et al. Among authors: pinover wh. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):277-81. doi: 10.1016/s0360-3016(02)02706-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023130

4

Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy.

Pinover WH, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE. Pinover WH, et al. Cancer. 2003 Feb 15;97(4):1127-33. doi: 10.1002/cncr.11166. Cancer. 2003. PMID: 12569615 Free article.

5

Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I. Bruner DW, et al. Oncology (Williston Park). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas. Oncology (Williston Park). 1999. PMID: 10204154

6

Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy.

Anderson PR, Hanlon AL, Horwitz E, Pinover W, Hanks GE. Anderson PR, et al. Cancer. 2000 Dec 15;89(12):2565-9. doi: 10.1002/1097-0142(20001215)89:12<2565::aid-cncr8>3.0.co;2-i. Cancer. 2000. PMID: 11135217

7

Conformal external beam treatment of prostate cancer.

Hanks GE, Hanlon AL, Schultheiss TE, Freedman GM, Hunt M, Pinover WH, Movsas B. Hanks GE, et al. Among authors: pinover wh. Urology. 1997 Jul;50(1):87-92. doi: 10.1016/s0090-4295(97)00226-4. Urology. 1997. PMID: 9218024

8

The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.

Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. Horwitz EM, et al. Among authors: pinover wh. Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):519-23. doi: 10.1016/s0360-3016(98)00095-9. Int J Radiat Oncol Biol Phys. 1998. PMID: 9635697

9

Hypoxic regions exist in human prostate carcinoma.

Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Movsas B, et al. Among authors: pinover wh. Urology. 1999 Jan;53(1):11-8. doi: 10.1016/s0090-4295(98)00500-7. Urology. 1999. PMID: 9886581

10

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer.

Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Tricoli JV, et al. Among authors: pinover wh. Urology. 1999 Jul;54(1):178-82. doi: 10.1016/s0090-4295(99)00129-6. Urology. 1999. PMID: 10414748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters